/TD>
|
|
Links
Home FDA Information |
AloxiThis page contains recent news articles, when available, and an overview of AloxiRecent news articles mentioning AloxiHELSINN HEALTHCARE SA Announces Patent Extension for Aloxi(R ... - Feb 15, 2007 Drug Newswire (press release), Helsinn HEALTHCARE SA is a privately owned pharmaceutical group with headquarters in Switzerland and is the worldwide licensor of palonosetron. HELSINN HEALTHCARE SA Announces Patent Extension for Aloxi(R ... - Feb 13, 2007 Earthtimes.org ...patent term extensionhas been granted by the US Patent and Trademark Office for the patentcovering Aloxi(R) (palonosetron hydrochloride) Injection. MGI PHARMA Reports Fourth Quarter and Full Year 2006 Financial Results - Feb 8, 2007 PharmaLive.com (press release), During the fourth quarter of 2006, US sales of Aloxi(R) (palonosetron hydrochloride) Injection totaled $49.6 million compared to $67.0 million in the fourth MGI Pharma to Present at the 2007 Merrill Lynch Global ... - Feb 1, 2007 PharmaLive.com (press release), MGI PHARMA markets Aloxi(R) (palonosetron hydrochloride) Injection, Dacogen(TM) (decitabine) for Injection and Gliadel(R) Wafer (polifeprosan 20 with MGI PHARMA to Present at the 2007 Merrill Lynch Global ... - Jan 31, 2007 dBusinessNews Minneapolis (press release), MGI PHARMA markets Aloxi® (palonosetron hydrochloride) Injection, Dacogen™ (decitabine) for Injection and Gliadel® Wafer (polifeprosan 20 with carmustine Synta Pharmaceuticals Corp. Announces Additions to Senior ... - Jan 23, 2007 PharmaLive.com (press release), Dr. Sonderfan began his industry career at Syntex, Inc. as Nonclinical Leader, Palonosetron Program. Dr. Sonderfan earned his BS in Toxicology from the Other uses for Aloxi [MedMaster Patient Drug Information database] Before taking pregabalin,
|